Oramed Pharmaceuticals Inc. Common Stock ORMP
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T00:46:55.664Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:00.619556835Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-12T00:44:59.547432+00:00
Oramed Pharmaceuticals Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | 4.87 | 101.3% | 25.5% | |||
| 40Δ | 4.64 | 111.6% | 23.6% | |||
| 45Δ | 4.41 | 121.9% | 21.8% | 5.12 | 250.4% | 23.9% |
| 50Δ | 4.18 | 132.2% | 19.9% | 5.41 | 237.3% | 21.2% |
| 55Δ | 3.95 | 142.4% | 18.1% | 5.70 | 224.2% | 18.5% |
| 60Δ | 3.72 | 152.7% | 16.3% | 5.99 | 211.1% | 15.8% |
| 65Δ | 3.49 | 163.0% | 14.4% | 6.29 | 198.0% | 13.1% |
| 70Δ | 3.26 | 173.2% | 12.6% | 6.58 | 184.9% | 10.4% |
| 75Δ | 3.03 | 183.5% | 10.7% | 6.87 | 171.8% | 7.7% |
| 80Δ | 2.80 | 193.8% | 8.9% | 7.16 | 158.7% | 5.0% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 4.87
- IV
- 101.3%
- B/E move
- 25.5%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 4.64
- IV
- 111.6%
- B/E move
- 23.6%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 4.41
- IV
- 121.9%
- B/E move
- 21.8%
- Pseudo strike
- 5.12
- IV
- 250.4%
- B/E move
- 23.9%
50Δ
- Pseudo strike
- 4.18
- IV
- 132.2%
- B/E move
- 19.9%
- Pseudo strike
- 5.41
- IV
- 237.3%
- B/E move
- 21.2%
55Δ
- Pseudo strike
- 3.95
- IV
- 142.4%
- B/E move
- 18.1%
- Pseudo strike
- 5.70
- IV
- 224.2%
- B/E move
- 18.5%
60Δ
- Pseudo strike
- 3.72
- IV
- 152.7%
- B/E move
- 16.3%
- Pseudo strike
- 5.99
- IV
- 211.1%
- B/E move
- 15.8%
65Δ
- Pseudo strike
- 3.49
- IV
- 163.0%
- B/E move
- 14.4%
- Pseudo strike
- 6.29
- IV
- 198.0%
- B/E move
- 13.1%
70Δ
- Pseudo strike
- 3.26
- IV
- 173.2%
- B/E move
- 12.6%
- Pseudo strike
- 6.58
- IV
- 184.9%
- B/E move
- 10.4%
75Δ
- Pseudo strike
- 3.03
- IV
- 183.5%
- B/E move
- 10.7%
- Pseudo strike
- 6.87
- IV
- 171.8%
- B/E move
- 7.7%
80Δ
- Pseudo strike
- 2.80
- IV
- 193.8%
- B/E move
- 8.9%
- Pseudo strike
- 7.16
- IV
- 158.7%
- B/E move
- 5.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 175.49% | |
| 206.76% |
Biotechnology
OTLK
Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company…
More →OVID
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is…
More →PBLS
Parabilis Medicines, Inc. (Ticker: PBLS) is an emerging company at the forefront of the telecommunications sector, dedicated to delivering innovative communication solutions…
More →PBYI
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and…
More →PCVX
Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally. The company is headquartered in Foster City,…
More →PDSB
PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies. The company is headquartered in Florham…
More →